Supriya Lifescience Limited (NSE:SUPRIYA)
India · Delayed Price · Currency is INR 644.45
+6.55 (1.03%)
Nov 12, 2026, 3:29 PM IST
Supriya Lifescience Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 8,786 | 8,279 | 6,965 | 5,703 | 4,609 | 5,300 |
Revenue Growth | 22.93% | 18.87% | 22.12% | 23.73% | -13.04% | 35.49% |
Gross Profit Gross Profit Growth | 5,492 | 5,385 | 4,622 | 3,381 | 2,649 | 3,266 |
Operating Income Operating Income Growth | 2,293 | 2,665 | 2,405 | 1,602 | 1,172 | 2,043 |
Net Income Net Income Growth | 1,772 | 2,091 | 1,880 | 1,191 | 898.57 | 1,518 |
Earnings Per Share EPS Growth | 22.01 | 25.98 | 23.35 | 14.80 | 11.16 | 18.86 |
EPS Growth | -3.00% | 11.26% | 57.77% | 32.62% | -40.83% | 11.68% |
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Asia Asia Growth | 2,732 | - | - | - | - |
Europe Europe Growth | 3,312 | - | - | - | - |
Latin America Latin America Growth | 1,656 | - | - | - | - |
North America North America Growth | 248.36 | - | - | - | - |
Others Others Growth | 331.15 | - | - | - | - |
Export Export Growth | - | 6,465 | 5,001 | 3,989 | 4,264 |
India India Growth | - | 1,185 | 1,339 | 1,076 | 1,514 |
Unallocated Unallocated Growth | - | -854.37 | -765.86 | -555.31 | -584.69 |
Total Total Growth | 8,279 | 6,796 | 5,574 | 4,510 | 5,194 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 759.31 | 788.67 | 791.54 | 749.56 | 1,576 | 2,249 |
Total Debt Total Debt Growth | 58.03 | 54.35 | 53.8 | 54.88 | 224.68 | 274.15 |
Net Cash (Debt) Net Cash Growth | 701.28 | 734.32 | 737.74 | 694.68 | 1,351 | 1,975 |
Net Cash Growth | -28.43% | -0.46% | 6.20% | -48.59% | -31.59% | 1287.90% |
Net Cash Per Share Net Cash Per Share Growth | 8.71 | 9.12 | 9.17 | 8.63 | 16.79 | 24.54 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 1,911 | 1,858 | 1,647 | 1,133 | 636.05 | 488.01 |
Capital Expenditures CapEx Growth | -1,454 | -1,522 | -1,624 | -1,457 | -1,079 | -599.04 |
Free Cash Flow Free Cash Flow Growth | 456.68 | 335.34 | 22.99 | -323.48 | -443.05 | -111.03 |
Free Cash Flow Growth | - | 1358.63% | - | - | - | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 62.52% | 65.05% | 66.36% | 59.28% | 57.46% | 61.61% |
Operating Margin | 26.10% | 32.20% | 34.53% | 28.10% | 25.42% | 38.55% |
Pretax Margin | 27.05% | 33.19% | 35.68% | 29.05% | 26.79% | 39.10% |
Profit Margin | 20.17% | 25.26% | 26.99% | 20.89% | 19.49% | 28.64% |
FCF Margin | 5.20% | 4.05% | 0.33% | -5.67% | -9.61% | -2.10% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 1.000 | 1.000 | 1.000 | 0.800 | 0.600 | 0.600 |
Dividend Per Share Growth | 0% | 0% | 25.00% | 33.33% | 0% | 11.11% |
Dividend Yield | 0.16% | 0.18% | 0.14% | 0.24% | 0.32% | 0.12% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 29.28 | 21.63 | 31.44 | 22.50 | 17.09 | 26.15 |
P/FCF Ratio | 113.57 | 134.86 | 2570.09 | - | - | - |
PS Ratio | 5.90 | 5.46 | 8.48 | 4.70 | 3.33 | 7.49 |